{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:46:32Z","timestamp":1791189992428,"version":"4.1.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.biologicals.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T23:18:52Z","timestamp":1307575132000},"page":"129-142","source":"Crossref","is-referenced-by-count":132,"title":["Antivenoms for the treatment of snakebite envenomings: The road ahead"],"prefix":"10.1016","volume":"39","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Burnouf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2011.02.005_bib1","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1371\/journal.pmed.0030150","article-title":"Confronting the neglected problem of snake bite envenoming: the need for a global partnership","volume":"3","author":"Guti\u00e9rrez","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib2","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"Harrison","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.biologicals.2011.02.005_bib3","series-title":"Rabies and envenomings. A neglected public health issue","author":"WHO","year":"2007"},{"key":"10.1016\/j.biologicals.2011.02.005_bib4","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib5","series-title":"Envenomings and their treatments","first-page":"3","article-title":"Serum therapy was discovered 100 years ago","author":"Bon","year":"1996"},{"key":"10.1016\/j.biologicals.2011.02.005_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0041-0101(94)90087-6","article-title":"Caprylic acid fractionation of hyperimmune horse plasma: description of a simple procedure for antivenom production","volume":"32","author":"Rojas","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib7","series-title":"Manual de Procedimientos: Producci\u00f3n y Pruebas de Control en la Preparaci\u00f3n de Antisueros Dift\u00e9rico, Tet\u00e1nico, Botul\u00ednico, Antivenenos y de la Gangrena Gaseosa","first-page":"104","article-title":"Antivenenos","author":"Bola\u00f1os","year":"1977"},{"key":"10.1016\/j.biologicals.2011.02.005_bib8","series-title":"Handbook of natural toxins","first-page":"557","article-title":"Antivenins in Brazil: preparation","author":"Raw","year":"1991"},{"key":"10.1016\/j.biologicals.2011.02.005_bib9","series-title":"Envenomings and their treatments","first-page":"161","article-title":"Preparation of improved F(ab\u2019)2 antivenoms. An example: new polyvalent European viper antivenom (equine)","author":"Grandgeorge","year":"1996"},{"key":"10.1016\/j.biologicals.2011.02.005_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0041-0101(03)00170-3","article-title":"Formulation of a liquid ovine Fab-based antivenom for the treatment of envenomation by the Nigerian carpet viper (Echis ocellatus)","volume":"42","author":"Al-Abdulla","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib11","unstructured":"WHO. WHO Guidelines for the production, control and regulation of snake antivenom immunoglobulins 2010 World Health Organization Geneva"},{"key":"10.1016\/j.biologicals.2011.02.005_bib12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0041-0101(91)90116-9","article-title":"Snake venom variability: methods of study, results and interpretation","volume":"29","author":"Chippaux","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib13","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.jprot.2010.06.001","article-title":"Snake venomics and antivenomics of Crotalus durissus subspecies from Brazil: assessment of geographic variation and its implication on snakebite management","volume":"73","author":"Boldrini-Franca","year":"2010","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib14","unstructured":"Guti\u00e9rrez JM, Le\u00f3n G, Lomonte B, Angulo Y. Antivenoms for the treatment of snakebite envenomings. Curr Immunol Rev, in press."},{"key":"10.1016\/j.biologicals.2011.02.005_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/pmic.200700777","article-title":"Exploring snake venom proteomes: multifaceted analyses for complex toxin mixtures","volume":"8","author":"Fox","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jprot.2009.01.008","article-title":"Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming","volume":"72","author":"Guti\u00e9rrez","year":"2009","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib17","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.febslet.2009.03.029","article-title":"Venoms, venomics, antivenomics","volume":"583","author":"Calvete","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2011.02.005_bib18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.toxicon.2009.12.009","article-title":"Intra-specific variation in venom of the African Puff Adder (Bitis arietans): differential expression and activity of snake venom metalloproteinases (SVMPs)","volume":"55","author":"Currier","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-4165(99)00053-7","article-title":"Comparative characterisation of Russell\u2019s viper (Daboia\/Vipera russelli) venoms from different regions of the Indian peninsula","volume":"1428","author":"Prasad","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2011.02.005_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jprot.2009.07.013","article-title":"Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Peru and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism","volume":"73","author":"N\u00fa\u00f1ez","year":"2009","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.toxicon.2010.01.015","article-title":"A\u00a0study on the venom of Bothrops alternatus Dumeril, Bibron and Dumeril, from different regions of Argentina","volume":"55","author":"Lanari","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.toxicon.2010.02.028","article-title":"Evolutionary trends in venom composition in the western rattlesnakes (Crotalus viridis sensu lato): toxicity vs. tenderizers","volume":"55","author":"Mackessy","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib23","doi-asserted-by":"crossref","first-page":"e1194","DOI":"10.1371\/journal.pone.0001194","article-title":"Reappraisal of Vipera aspis venom neurotoxicity","volume":"2","author":"Ferquel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2011.02.005_bib24","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/pr9008749","article-title":"Snake venomics of the Central American rattlesnake Crotalus simus and the South American Crotalus durissus complex points to neurotoxicity as an adaptive paedomorphic trend along Crotalus dispersal in South America","volume":"9","author":"Calvete","year":"2010","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.biologicals.2011.02.005_bib25","first-page":"337","article-title":"Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications","volume":"50","author":"Saravia","year":"2002","journal-title":"Rev Biol Trop"},{"key":"10.1016\/j.biologicals.2011.02.005_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0041-0101(91)90201-2","article-title":"Biochemical and pharmacological similarities between the venoms of newborn Crotalus durissus durissus and adult Crotalus durissus terrificus rattlesnakes","volume":"29","author":"Guti\u00e9rrez","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib27","series-title":"The venomous reptiles of the western hemisphere","first-page":"709","article-title":"Snakebites in Central and South America: epidemiology, clinical features, and clinical management","author":"Warrell","year":"2004"},{"key":"10.1016\/j.biologicals.2011.02.005_bib28","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.129.3359.1361","article-title":"Geographical pattern of crotamine distribution in the same rattlesnake subspecies","volume":"129","author":"Schenberg","year":"1959","journal-title":"Science"},{"key":"10.1016\/j.biologicals.2011.02.005_bib29","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.toxicon.2009.12.015","article-title":"Antivenomics and venom phenotyping: a marriage of convenience to address the performance and range of clinical use of antivenoms","volume":"56","author":"Calvete","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib30","series-title":"Determinaci\u00f3n de Actividades T\u00f3xicas de Venenos de Serpientes y su Neutralizaci\u00f3n por Antivenenos. Manual de M\u00e9todos de Laboratorio","author":"Anonymous","year":"2008"},{"key":"10.1016\/j.biologicals.2011.02.005_bib31","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4269\/ajtmh.2010.09-0733","article-title":"Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa","volume":"82","author":"Calvete","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.toxicon.2010.07.001","article-title":"Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms","volume":"56","author":"Segura","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib33","first-page":"153","article-title":"Cross-reactivity of horse monovalent antivenoms to venoms of ten Bothrops species","volume":"51","author":"Dias-da-Silva","year":"1989","journal-title":"Mem Inst Butantan"},{"key":"10.1016\/j.biologicals.2011.02.005_bib34","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.vaccine.2003.09.046","article-title":"Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming","volume":"22","author":"Harrison","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.02.005_bib35","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1371\/journal.pmed.0030184","article-title":"Bioinformatics and multiepitope DNA immunization to design rational snake antivenom","volume":"3","author":"Wagstaff","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib36","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.trstmh.2004.09.014","article-title":"Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa","volume":"99","author":"Guti\u00e9rrez","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib37","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.trstmh.2008.03.023","article-title":"Frequent and potentially fatal envenoming by hump-nosed pit vipers (Hypnale hypnale and H.\u00a0nepa) in Sri Lanka: lack of effective antivenom","volume":"102","author":"Ariaratnam","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.toxicon.2010.06.026","article-title":"Hyponatraemia, rhabdomyolysis, alterations in blood pressure and persistent mydriasis in patients envenomed by Malayan kraits (Bungarus candidus) in southern Viet Nam","volume":"56","author":"Trinh","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4269\/ajtmh.1995.52.419","article-title":"Prevention of thromboses in human patients with Bothrops lanceolatus envenoming in Martinique: failure of anticoagulants and efficacy of a monospecific antivenom. Research Group on Snake Bites in Martinique","volume":"52","author":"Thomas","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib40","series-title":"Handbook of clinical toxicology of animal venoms and poisons","first-page":"493","article-title":"Clinical toxicology of snakebite in Asia","author":"Warrell","year":"1995"},{"key":"10.1016\/j.biologicals.2011.02.005_bib41","unstructured":"Quijada-Mascare\u00f1as A, W\u00fcster W. Recent advances in venomous snake systematics In: Mackessy SP, editor. Handbook of venoms and toxins of reptiles Boca Raton: CRC Press. p. 25\u201364."},{"key":"10.1016\/j.biologicals.2011.02.005_bib42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0041-0101(96)00152-3","article-title":"Synopsis of recent developments in venomous snake systematics","volume":"35","author":"W\u00fcster","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib43","unstructured":"Le\u00f3n G, S\u00e1nchez L, Hern\u00e1ndez A, Villalta M, Herrera M, Segura A, et\u00a0al. Immune response towards snake venoms. Curr Immunol Rev, in press."},{"key":"10.1016\/j.biologicals.2011.02.005_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1081\/CLT-120021113","article-title":"Snake antivenoms","volume":"41","author":"Lalloo","year":"2003","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib45","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.toxicon.2006.09.005","article-title":"Strengthening antivenom production in Central and South American public laboratories: report of a workshop","volume":"49","author":"Guti\u00e9rrez","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib46","series-title":"Animal toxins: state of the art perspectives in health and biotechnology","first-page":"393","article-title":"Snake antivenoms: Technological, clinical and public health issues","author":"Guti\u00e9rrez","year":"2009"},{"key":"10.1016\/j.biologicals.2011.02.005_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.toxicon.2010.03.025","article-title":"Analysis of camelid IgG for antivenom development: serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa","volume":"56","author":"Cook","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.toxicon.2009.07.031","article-title":"Neutralization of Bothrops mattogrossensis snake venom from Bolivia: experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation","volume":"55","author":"Fern\u00e1ndez","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib49","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/0041-0101(92)90046-8","article-title":"Comparison of the purity and efficacy of affinity purified avian antivenoms with commercial equine crotalid antivenoms","volume":"30","author":"Carroll","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/vr.143.21.579","article-title":"Development of snake antivenom antibodies in chickens and their purification from yolk","volume":"143","author":"Almeida","year":"1998","journal-title":"Vet Rec"},{"key":"10.1016\/j.biologicals.2011.02.005_bib51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.intimp.2008.03.017","article-title":"Studies on pharmacological effects of Russell\u2019s viper and saw-scaled viper venom and its neutralization by chicken egg yolk antibodies","volume":"8","author":"Meenatchisundaram","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.toxicon.2009.11.004","article-title":"Brazilian IgY-Bothrops antivenom: studies on the development of a process in chicken egg yolk","volume":"55","author":"Araujo","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib53","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.toxicon.2010.06.004","article-title":"Analysis of camelid IgG for antivenom development: immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment","volume":"56","author":"Cook","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-2427(96)05618-8","article-title":"Separation of equine IgG subclasses (IgGa, IgGb and IgG(T)) using their differential binding characteristics for staphylococcal protein A and streptococcal protein G","volume":"55","author":"Sheoran","year":"1996","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib55","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/0041-0101(91)90124-A","article-title":"Isolation of IgGT from hyperimmune horse anti-snake venom serum: its protective ability","volume":"29","author":"Fernandes","year":"1991","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.smallrumres.2005.03.009","article-title":"Immunochemical analysis of IgG subclases and IgM in south American camelids","volume":"64","author":"de Simone","year":"2006","journal-title":"Small Rumin Res"},{"key":"10.1016\/j.biologicals.2011.02.005_bib57","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.toxicon.2007.06.009","article-title":"On the presence of antibodies against bovine, equine and poultry immunoglobulins in human IgG preparations, and its implications on antivenom production","volume":"51","author":"Sevcik","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.toxicon.2005.08.004","article-title":"Factors associated with adverse reactions induced by caprylic acid-fractionated whole IgG preparations: comparison between horse, sheep and camel IgGs","volume":"46","author":"Herrera","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0041-0101(94)90294-1","article-title":"A\u00a0comparison of ovine and equine antivenoms","volume":"32","author":"Sjostrom","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/TXR-120019017","article-title":"Merits of sheep antisera for antivenom manufacture","volume":"22","author":"Landon","year":"2003","journal-title":"J\u00a0Toxicol Toxin Rev"},{"key":"10.1016\/j.biologicals.2011.02.005_bib61","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1371\/journal.pntd.0000767","article-title":"Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria","volume":"4","author":"Abubakar","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.biologicals.2011.02.005_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1439-0442.2003.00528.x","article-title":"Automated plasmapheresis compared with other plasma collection methods in the horse","volume":"50","author":"Feige","year":"2003","journal-title":"J\u00a0Vet Med A Physiol Pathol Clin Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0041-0101(01)00245-8","article-title":"Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil","volume":"40","author":"Camey","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0041-0101(00)00208-7","article-title":"Proteolytic action of Bothrops jararaca venom upon its own constituents","volume":"39","author":"Sousa","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib65","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0041-0101(90)90019-4","article-title":"Active immunization of rabbit with gamma irradiated Russell\u2019s viper venom toxoid","volume":"28","author":"Hati","year":"1990","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib66","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0041-0101(97)00114-1","article-title":"Inhibition by CaNa2EDTA of local tissue damage induced by Bothrops asper (terciopelo) venom: application in horse immunization for antivenom production","volume":"36","author":"Le\u00f3n","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0041-0101(98)00249-9","article-title":"Toxicity and immunogenicity of Crotalus durissus terrificus venom treated with different doses of gamma rays","volume":"37","author":"Clissa","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.toxicon.2010.01.027","article-title":"Effects of heating on the immunogenicity and biological toxicity of Deinagkistrodon acutus venom and its fractions","volume":"56","author":"Tang","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.toxicon.2004.12.006","article-title":"The improvement of the therapeutic anti-Lachesis muta serum production in horses","volume":"45","author":"Stephano","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib70","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.toxicon.2004.07.004","article-title":"Immunosuppressive role of principal toxin (crotoxin) of Crotalus durissus terrificus venom","volume":"44","author":"Rangel-Santos","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib71","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.toxicon.2005.01.009","article-title":"Inhibitory effect of phospholipase A2 isolated from Crotalus durissus terrificus venom on macrophage function","volume":"45","author":"Sampaio","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund\u2019s complete and other adjuvants","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J"},{"key":"10.1016\/j.biologicals.2011.02.005_bib73","first-page":"511","article-title":"Production of monovalent anti-Bothrops asper antivenom: development of immune response in horses and neutralizing ability","volume":"36","author":"Guti\u00e9rrez","year":"1988","journal-title":"Rev Biol Trop"},{"key":"10.1016\/j.biologicals.2011.02.005_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJM198407053110119","article-title":"Immunization against snake venoms","volume":"311","author":"New","year":"1984","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib75","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.vaccine.2008.11.103","article-title":"Comparison of Montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund\u2019s adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom","volume":"27","author":"Waghmare","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.02.005_bib76","unstructured":"Bola\u00f1os R, Cerdas L. Producci\u00f3n y control de sueros antiof\u00eddicos en Costa Rica Bol Of Sanit Panam, 1980; 88: 189\u201396."},{"key":"10.1016\/j.biologicals.2011.02.005_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15569548809059725","article-title":"Snake venom immunology: historical and practical considerations","volume":"7","author":"Russell","year":"1988","journal-title":"J\u00a0Toxicol Toxin Rev"},{"key":"10.1016\/j.biologicals.2011.02.005_bib78","first-page":"281","article-title":"Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparison of four different procedures","volume":"24","author":"Freitas","year":"1991","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.biologicals.2011.02.005_bib79","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0041-0101(01)00108-8","article-title":"Production of potent polyvalent antivenom against three elapid venoms using a low dose, low volume, multi-site immunization protocol","volume":"39","author":"Chotwiwatthanakun","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0035-9203(98)90802-1","article-title":"Clinical safety of a polyvalent F(ab\u2019)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon","volume":"92","author":"Chippaux","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib81","first-page":"315","article-title":"Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil","volume":"86","author":"Cardoso","year":"1993","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib82","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4269\/ajtmh.1998.58.183","article-title":"A\u00a0randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia","volume":"58","author":"Otero-Pati\u00f1o","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib83","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0035-9203(01)90339-6","article-title":"An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell\u2019s viper (Daboia russelii russelii)","volume":"95","author":"Ariaratnam","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib84","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1580\/1080-6032(2003)14[220:SSFAOA]2.0.CO;2","article-title":"Serum sickness following administration of antivenin (Crotalidae) polyvalent in 181 cases of presumed rattlesnake envenomation","volume":"14","author":"LoVecchio","year":"2003","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib85","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4269\/ajtmh.2007.77.538","article-title":"Clinical trial of an F(ab\u2019)2 polyvalent equine antivenom for African snake bites in Benin","volume":"77","author":"Chippaux","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib86","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.318.7190.1041","article-title":"Low dose subcutaneous adrenaline to prevent acute adverse reactions to antivenom serum in people bitten by snakes: randomised, placebo controlled trial","volume":"318","author":"Premawardhena","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.biologicals.2011.02.005_bib87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5694\/j.1326-5377.2004.tb05768.x","article-title":"Parallel infusion of hydrocortisone\u00a0+\/\u2212 chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites","volume":"180","author":"Gawarammana","year":"2004","journal-title":"Med J Aust"},{"key":"10.1016\/j.biologicals.2011.02.005_bib88","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0041-0101(98)00220-7","article-title":"A\u00a0randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms","volume":"37","author":"Otero","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib89","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0041-0101(00)00209-9","article-title":"Comparison between IgG and F(ab\u2019)2 polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions","volume":"39","author":"Le\u00f3n","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib90","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.toxicon.2004.07.025","article-title":"Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols","volume":"45","author":"Le\u00f3n","year":"2005","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib91","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.trstmh.2006.01.006","article-title":"Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia","volume":"100","author":"Otero","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib92","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-1759(03)00005-X","article-title":"A\u00a0protocol for \u2018enhanced pepsin digestion\u2019: a step by step method for obtaining pure antibody fragments in high yield from serum","volume":"275","author":"Jones","year":"2003","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biologicals.2011.02.005_bib93","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0041-0101(89)90177-3","article-title":"Purification of F(ab\u2019)2 anti-snake venom by caprylic acid: a fast method for obtaining IgG fragments with high neutralization activity, purity and yield","volume":"27","author":"dos Santos","year":"1989","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2003.07.014","article-title":"Fractionation of equine antivenom using caprylic acid precipitation in combination with cationic ion-exchange chromatography","volume":"282","author":"Raweerith","year":"2003","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biologicals.2011.02.005_bib95","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0041-0101(92)90384-H","article-title":"An affinity purified ovine antivenom for the treatment of Vipera berus envenoming","volume":"30","author":"Smith","year":"1992","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0041-0101(94)00175-8","article-title":"Experimental assessment of a new, low-cost antivenom for treatment of carpet viper (Echis ocellatus) envenoming","volume":"33","author":"Laing","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib97","series-title":"Envenomings and their treatments","first-page":"173","article-title":"Development of novel antivenoms based on specific ovine Fab","author":"Landon","year":"1996"},{"key":"10.1016\/j.biologicals.2011.02.005_bib98","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0032-9592(02)00243-1","article-title":"Optimization of buffer conditions for the removal of endotoxins using Q-Sepharose","volume":"38","author":"Lee","year":"2003","journal-title":"Process Biochem"},{"key":"10.1016\/j.biologicals.2011.02.005_bib99","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4269\/ajtmh.1985.34.141","article-title":"Preparation of a new antivenin by affinity chromatography","volume":"34","author":"Russell","year":"1985","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2011.02.005_bib100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0196-0644(97)70107-0","article-title":"Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning","volume":"30","author":"Dart","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib101","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/bit.21614","article-title":"Purification of equine IgG using membrane based enhanced hybrid bioseparation technique: a potential method for manufacturing hyperimmune antibody","volume":"99","author":"Wang","year":"2008","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.biologicals.2011.02.005_bib102","first-page":"497","article-title":"Economic evaluation of snake antivenom production in the public system","volume":"12","author":"Morais","year":"2006","journal-title":"J\u00a0Venom Anim Toxins incl Trop Dis"},{"key":"10.1016\/j.biologicals.2011.02.005_bib103","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.144.4.1387","article-title":"A\u00a0view of the human idiotypic repertoire. Electron microscopic and immunologic analyses of spontaneous idiotype-anti-idiotype dimers in pooled human IgG","volume":"144","author":"Roux","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0041-0101(93)90357-O","article-title":"Turbidity of hyperimmune equine antivenom: the role of phenol and serum lipoproteins","volume":"31","author":"Rojas","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/biol.2002.0329","article-title":"Effect of preservatives on IgG aggregation, complement-activating effect and hypotensive activity of horse polyvalent antivenom used in snakebite envenomation","volume":"30","author":"Garc\u00eda","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"Wang","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2011.02.005_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.04.018","article-title":"Freeze drying\u2013principles and practice for successful scale-up to manufacturing","volume":"280","author":"Tsinontides","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2011.02.005_bib108","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0041-0101(97)00101-3","article-title":"Thermal stability studies of hyperimmune horse antivenoms","volume":"37","author":"Rodrigues-Silva","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib109","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.toxicon.2009.01.012","article-title":"Stability of equine IgG antivenoms obtained by caprylic acid precipitation: towards a liquid formulation stable at tropical room temperature","volume":"53","author":"Segura","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1423-0410.2009.01226.x","article-title":"Intravenous immunoglobulin G: trends in production methods, quality control and quality assurance","volume":"98","author":"Radosevich","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2011.02.005_bib111","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib112","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biologicals.2004.07.001","article-title":"Assessment of the viral safety of antivenoms fractionated from equine plasma","volume":"32","author":"Burnouf","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib113","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.biologicals.2006.11.003","article-title":"Assessment of viral inactivation during pH 3.3\u00a0p.psin digestion and caprylic acid treatment of antivenoms","volume":"35","author":"Burnouf","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib114","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biologicals.2007.02.004","article-title":"Partitioning and inactivation of viruses by the caprylic acid precipitation followed by a terminal pasteurization in the manufacturing process of horse immunoglobulins","volume":"35","author":"Mpandi","year":"2007","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/biol.2002.0335","article-title":"Inactivation of West-Nile virus during peptic cleavage of horse plasma IgG","volume":"30","author":"Lazar","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib116","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/biol.2000.0254","article-title":"The removal of viruses during the purification of equine antisera using filtration aids Hyflo Super-Cel and Fulmon Super A","volume":"28","author":"Cameron-Smith","year":"2000","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib117","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2516.2003.00701.x","article-title":"Nanofiltration of plasma-derived biopharmaceutical products","volume":"9","author":"Burnouf","year":"2003","journal-title":"Haemophilia"},{"key":"10.1016\/j.biologicals.2011.02.005_bib118","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157341305774642894","article-title":"Place of nanofiltration for assuring viral safety of biologicals","volume":"1","author":"Burnouf","year":"2005","journal-title":"Curr Nanoscience"},{"key":"10.1016\/j.biologicals.2011.02.005_bib119","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.biologicals.2009.05.003","article-title":"Assessment of the impact of solvent\/detergent treatment on the quality and potency of a whole IgG equine antivenom","volume":"37","author":"Segura","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tmrv.2006.11.001","article-title":"Modern plasma fractionation","volume":"21","author":"Burnouf","year":"2007","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.biologicals.2011.02.005_bib121","unstructured":"WHO Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products Geneva www.WHO.int\/bloodproducts 2003."},{"key":"10.1016\/j.biologicals.2011.02.005_bib122","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tracli.2006.11.001","article-title":"Current strategies to prevent transmission of prions by human plasma derivatives","volume":"13","author":"Burnouf","year":"2006","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib123","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.2000.01287.x","article-title":"Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom","volume":"121","author":"Harrison","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib124","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.toxicon.2008.05.023","article-title":"Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom","volume":"52","author":"Azofeifa-Cordero","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib125","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2008.10.066","article-title":"Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper","volume":"27","author":"Arce-Estrada","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2011.02.005_bib126","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0041-0101(84)90141-7","article-title":"Cellular and mitochondrial changes induced in the structure of murine skeletal muscle by crotoxin, a neurotoxic phospholipase A2 complex","volume":"22","author":"Gopalakrishnakone","year":"1984","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib127","first-page":"333","article-title":"Isolation and characterization of a thrombin-like enzyme from the venom of Crotalus durissus terrificus","volume":"19","author":"Raw","year":"1986","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.biologicals.2011.02.005_bib128","series-title":"Venom phospholipase A2 enzymes: structure, function and mechanism","first-page":"269","article-title":"Multicomponent neurotoxic phospholipases A2","author":"Bon","year":"1997"},{"key":"10.1016\/j.biologicals.2011.02.005_bib129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.toxicon.2006.04.010","article-title":"North and South American Loxosceles spiders: development of a polyvalent antivenom with recombinant sphingomyelinases D as antigens","volume":"48","author":"Olvera","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biologicals.2011.02.005_bib131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1423-0410.2010.01384.x","article-title":"Recombinant plasma proteins","volume":"100","author":"Burnouf","year":"2011","journal-title":"Vox Sang"},{"key":"10.1016\/j.biologicals.2011.02.005_bib132","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0014-5793(86)81024-9","article-title":"A\u00a0monoclonal antibody which recognized the functional site of snake neurotoxins and which neutralizes all short-chain variants","volume":"208","author":"Tremeau","year":"1986","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biologicals.2011.02.005_bib133","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0041-0101(88)90249-8","article-title":"Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin","volume":"26","author":"Lomonte","year":"1988","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib134","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0161-5890(92)90125-H","article-title":"Immunochemical analysis of a snake venom phospholipase A2 neurotoxin, crotoxin, with monoclonal antibodies","volume":"29","author":"Choumet","year":"1992","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib135","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0041-0101(99)00134-8","article-title":"Neutralization of the hemorrhagic activity of Bothrops and Lachesis snake venoms by a monoclonal antibody against mutalysin-II","volume":"38","author":"Estevao-Costa","year":"2000","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib136","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.toxicon.2003.10.011","article-title":"Phylogenetic conservation of a snake venom metalloproteinase epitope recognized by a monoclonal antibody that neutralizes hemorrhagic activity","volume":"42","author":"Tanjoni","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib137","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.toxicon.2010.07.014","article-title":"Immunochemical and biological characterization of monoclonal antibodies against BaP1, a metalloproteinase from Bothrops asper snake venom","volume":"56","author":"Fernandes","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib138","series-title":"Snake toxins","first-page":"35","article-title":"Snake venom immunology","author":"M\u00e9nez","year":"1991"},{"key":"10.1016\/j.biologicals.2011.02.005_bib139","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2003.10.015","article-title":"Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius hoffmann","volume":"43","author":"Selisko","year":"2004","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib140","series-title":"Animais Pe\u00e7onhentos no Brasil Biologia, Cl\u00ednica e Terap\u00eautica dos Acidentes","first-page":"367","article-title":"Produ\u00e7ao de soros antitoxinas e perspectivas de moderniza\u00e7\u00e3o por t\u00e9cnicas de Biologia Molecular","author":"Cardoso","year":"2003"},{"key":"10.1016\/j.biologicals.2011.02.005_bib141","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jms.1242","article-title":"Snake venomics. Strategy and applications","volume":"42","author":"Calvete","year":"2007","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.biologicals.2011.02.005_bib142","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/pmic.200400931","article-title":"A\u00a0multifaceted analysis of viperid snake venoms by two-dimensional gel electrophoresis: an approach to understanding venom proteomics","volume":"5","author":"Serrano","year":"2005","journal-title":"Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib143","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(95)02095-0","article-title":"Specificity and binding affinity of an anti-crotoxin combinatorial antibody selected from a phage-displayed library","volume":"50","author":"Meng","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib144","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1380-2933(97)00068-7","article-title":"Biologically active human anti-crotoxin scFv isolated from a semi-synthetic phage library","volume":"3","author":"Lafaye","year":"1997","journal-title":"Immunotechnology"},{"key":"10.1016\/j.biologicals.2011.02.005_bib145","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bbagen.2006.04.008","article-title":"Expression of recombinant human antibody fragments capable of inhibiting the phospholipase and myotoxic activities of Bothrops jararacussu venom","volume":"1760","author":"Tamarozzi","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2011.02.005_bib146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.toxicon.2006.11.023","article-title":"Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naive phage display library: preliminary findings for antivenom development","volume":"49","author":"Stewart","year":"2007","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib147","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jprot.2008.12.007","article-title":"Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin","volume":"72","author":"Kulkeaw","year":"2009","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib148","first-page":"1212","article-title":"The development of nanobodies for therapeutic applications","volume":"10","author":"Van Bockstaele","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.biologicals.2011.02.005_bib149","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","article-title":"VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI\u2019","volume":"45","author":"Hmila","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20090697","article-title":"Identification of potent nanobodies to neutralize the most poisonous polypeptide from scorpion venom","volume":"424","author":"Abderrazek","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.biologicals.2011.02.005_bib151","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1074\/jbc.M110.189175","article-title":"Exploiting cross-reactivity to neutralize two different scorpion venoms with one single-chain antibody fragment","volume":"286","author":"Ria\u00f1o-Umbarila","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2011.02.005_bib152","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/15563659409011037","article-title":"Antibody treatment of toxin poisoning\u2013recent advances","volume":"32","author":"Scherrmann","year":"1994","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib153","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of immunoglobulin therapy for envenomation","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.biologicals.2011.02.005_bib154","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mem.2001.113135","article-title":"Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 1. Pharmacokinetics and pharmacodynamics of immunoglobulin antivenoms and related antibodies","volume":"37","author":"Seifert","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.biologicals.2011.02.005_bib155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.biologicals.2010.05.006","article-title":"Study of the design and analytical properties of the lethality neutralization assay used to estimate antivenom potency against Bothrops asper snake venom","volume":"38","author":"Solano","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2011.02.005_bib156","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0041-0101(03)00125-9","article-title":"Animal experimentation in snake venom research and in vitro alternatives","volume":"42","author":"Sells","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib157","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.toxicon.2009.08.006","article-title":"Tissue pathology induced by snake venoms: how to understand a complex pattern of alterations from a systems biology perspective?","volume":"55","author":"Guti\u00e9rrez","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib158","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0041-0101(79)90284-8","article-title":"Enzyme-linked immunosorbent assay (ELISA) in assessing antivenom potency","volume":"17","author":"Theakston","year":"1979","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib159","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0041-0101(01)00130-1","article-title":"Determination of the neutralizing potency of horse antibothropic and anticrotalic antivenoms in blood samples collected on filter paper","volume":"39","author":"Maria","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.toxicon.2006.07.004","article-title":"A\u00a0new ELISA for determination of potency in snake antivenoms","volume":"48","author":"Rial","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib161","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0041-0101(96)00077-3","article-title":"Clinical and laboratory alterations in horses during immunization with snake venoms for the production of polyvalent (Crotalinae) antivenom","volume":"35","author":"Angulo","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib162","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0041-0101(96)00150-X","article-title":"A\u00a0comparison of in vitro methods for assessing the potency of therapeutic antisera against the venom of the coral snake Micrurus nigrocinctus","volume":"35","author":"Alape-Gir\u00f3n","year":"1997","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib163","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0041-0101(88)90010-4","article-title":"An alternative in vitro method for testing the potency of the polyvalent antivenom produced in Costa Rica","volume":"26","author":"Guti\u00e9rrez","year":"1988","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib164","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0041-0101(94)90079-5","article-title":"The use of the chick biventer cervicis preparation to assess the protective activity of six international reference antivenoms on the neuromuscular effects of snake venoms in vitro","volume":"32","author":"Barfaraz","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1006\/taap.2001.9233","article-title":"Species and regional variations in the effectiveness of antivenom against the in vitro neurotoxicity of death adder (Acanthophis) venoms","volume":"175","author":"Fry","year":"2001","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.biologicals.2011.02.005_bib166","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0041-0101(94)90408-1","article-title":"Broad cytolytic specificity of myotoxin II, a lysine-49\u00a0p.ospholipase A2 of Bothrops asper snake venom","volume":"32","author":"Lomonte","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib167","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vascn.2010.09.001","article-title":"Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms","volume":"63","author":"Kalam","year":"2011","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.biologicals.2011.02.005_bib168","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0041-0101(98)00004-X","article-title":"A\u00a0humane alternative to the measurement of the lethal effects (LD50) of non-neurotoxic venoms using hens\u2019 eggs","volume":"36","author":"Sells","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib169","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0041-0101(00)00191-4","article-title":"An in vivo but insensate model for the evaluation of antivenoms (ED50) using fertile hens\u2019 eggs","volume":"39","author":"Sells","year":"2001","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib170","series-title":"Venoms and toxins of reptiles","first-page":"287","article-title":"Snake venom three-finger toxins","author":"Hedge","year":"2009"},{"key":"10.1016\/j.biologicals.2011.02.005_bib171","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jprot.2008.10.003","article-title":"Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus","volume":"71","author":"Wagstaff","year":"2009","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.biologicals.2011.02.005_bib172","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.toxicon.2009.06.010","article-title":"Proteomic profiling of snake venom metalloproteinases (SVMPs): insights into venom induced pathology","volume":"54","author":"Terra","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib173","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.toxicon.2009.01.039","article-title":"Experimental pathophysiology of systemic alterations induced by Bothrops asper snake venom","volume":"54","author":"Guti\u00e9rrez","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.biologicals.2011.02.005_bib174","series-title":"The New Invisible College. Science for development","author":"Wagner","year":"2008"},{"key":"10.1016\/j.biologicals.2011.02.005_bib175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0140-6736(09)61159-4","article-title":"The global snake bite initiative: an antidote for snake bite","volume":"375","author":"Williams","year":"2010","journal-title":"Lancet"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105611000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T08:02:11Z","timestamp":1686124931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105611000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":175,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1045105611000418"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2011.02.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}